Pediatric Pertussis in Ambulatory Settings
National Surveillance of Pediatric Pertussis in Ambulatory Settings
Association Clinique Thérapeutique Infantile du val de Marne
898 participants
May 30, 2001
OBSERVATIONAL
Conditions
Summary
Since 2002, Whooping cough surveillance in pediatric private practice has been set up in France. The results of the first years, 2002-2006, have confirmed the effectiveness of the Pertussis whole-cell (Pw) vaccine and in particular the duration of protection of 9/10 years. After evaluating cases in children vaccinated with Pw vaccines, the study aims today to analyze cases in children vaccinated with Pertussis acellular (Pa) vaccines used since 2002/2003 and to assess, on an outpatient basis, the impact of new vaccine recommendations in France (in 2013, introduction of a 2 + 1 schedule - 8 weeks, 4 months and a 11-month recall - and a 6-year recall, and in 2014, update in the recommendations of exams to be prescribed based on the child's age and vaccination status).
Eligibility
Inclusion Criteria1
- All children under 18 years old with a pertussis diagnosis is suspected and a biological exam is requested
Exclusion Criteria2
- children without symptoms with a household confirmed case
- cases for which the pertussis diagnosis was not suspected by the pediatrician
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04807712